Targeting cancer cell death with a bcl-xS adenovirus Jeffrey S. HanGabriel NúñezMichael F. Clarke OriginalPaper Pages: 279 - 288
Receptors and ligands that mediate activation-induced death of T cells Mark R. AldersonDavid H. Lynch OriginalPaper Pages: 289 - 300
Clinical effects of mutations to CD95 (Fas): relevance to autoimmunity? Jean-Pierre de VillartayFrédéric Rieux-LaucatFrançoise Le Deist OriginalPaper Pages: 301 - 310
Can expression of CD95 (Fas/APO-1) ligand on grafts or tumor cells prevent their rejection? Janette AllisonKen-ichiro SeinoHideo Yagita OriginalPaper Pages: 311 - 322
Lymphocyte granule-mediated cell death Joseph A. TrapaniDavid A. JansVivien R. Sutton OriginalPaper Pages: 323 - 343
Apoptosis by p53: mechanisms, regulation, and clinical implications Ronit Vogt SionovYgal Haupt OriginalPaper Pages: 345 - 362